New York Life Investment Management LLC Vaxcyte, Inc. Transaction History
New York Life Investment Management LLC
- $9.26 Billion
- Q1 2025
A detailed history of New York Life Investment Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 12,967 shares of PCVX stock, worth $431,152. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,967
Previous 12,469
3.99%
Holding current value
$431,152
Previous $1.02 Million
52.06%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$405 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$400 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$391 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$330 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$213 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $1.97B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...